Nie, S., Liu, D., Hu, J., Gan, Y., & Mi, L. (2026). TBX20 promotes doxorubicin resistance in breast cancer cells through enhanced ABCC1 expression and inhibition of mitophagy. PLoS ONE, 21(7), 1. https://doi.org/10.1371/journal.pone.0353376
Chicago Style (17th ed.) CitationNie, Shuai, Dejian Liu, Jun Hu, Yu Gan, and Liangliang Mi. "TBX20 Promotes Doxorubicin Resistance in Breast Cancer Cells Through Enhanced ABCC1 Expression and Inhibition of Mitophagy." PLoS ONE 21, no. 7 (2026): 1. https://doi.org/10.1371/journal.pone.0353376.
MLA (9th ed.) CitationNie, Shuai, et al. "TBX20 Promotes Doxorubicin Resistance in Breast Cancer Cells Through Enhanced ABCC1 Expression and Inhibition of Mitophagy." PLoS ONE, vol. 21, no. 7, 2026, p. 1, https://doi.org/10.1371/journal.pone.0353376.